OncoHealth Takes on HPV Testing Market with Protein-Based Assay | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – While the buzz around human papillomavirus testing has centered on DNA-based testing, a startup firm is looking to carve out a place in the market with protein-based tests that it says offer a critical advantage over DNA tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.